Bionano - BNGO Company Short-Term Debts

Official company branding of Bionano Genomics (BNGO)

The efficiency of Bionano Genomics, Inc. (BNGO) relies on the pace of laboratory installations of its instruments, the volume of grants, and the demand for rare pathology diagnostics. Patents for structural DNA change analysis and the complexity of nanochannel physics serve as a moat for the business. This price chart featuring the 0.00 indicator complements the strategy to capture the digital genetics segment by expanding the B2B supply network for software and Saphyr systems.

BNGO Bionano Genomics, Inc. Short-Term Debt (07/04/2022 - 11/01/2026)

Summary analytical data breakdowns for Bionano Genomics Inc. (BNGO)

- stock price and consensus target price:
Stock Price Bionano|BNGO - Price Target Chart
- issuer market value details:
Market Capitalization Bionano Genomics, Inc.|BNGO - Company Buyout Price
- business book valuation details:
Net Assets per Single Share Bionano Genomics|BNGO - Total Stockholders' Equity|Market Value to Book Value Ratio bionanogenomics.com|BNGO - Total Business Assets
- issuer credit burden and liquidity indicators:
Total Debt to Capital Bionano Genomics, Inc.|BNGO - Long-Term Debt to Capital|Short-Term Debt to Equity Bionano|BNGO - Company Aggregate Debt|Debt to Book Capitalization Ratio Bionano Genomics, Inc.|BNGO - Long-Term Debt|Company Current Liabilities Bionano Genomics|Quick Ratio bionanogenomics.com
- earnings and multiples data:
BNGO - Annual Net Income
Fundamental valuation:BNGO - bionanogenomics.com
Manufactured products of Bionano

Amid conservative budgeting by medical centers, which is constraining the expansion of optical genome mapping, managing short-term liabilities has become critical for Bionano Genomics, Inc. (BNGO). This indicator measures the company's ability to service current loans, allowing investors to assess liquidity risk and the precise balance between operational growth and default threat through the dynamics of short-term borrowed capital.

Main competitors

Tempus AI, Inc - Company Short-Term Debts|QGEN: Company Short-Term Debt|IONS: Company Short-Term Debts|RGEN - Short-Term Debt Volume|Company Short-Term Debt Avidity Biosciences|Short-Term Debt crisprtx.com CRSP|Company Short-Term Debt GeneDx (WGS)|Ultragenyx Pharmaceutical Inc. - Company Short-Term Indebtedness|Company Short-Term Debts BEAM (Beam Therapeutics Corp)|Company Short-Term Debts Sarepta Corp SRPT|TWST - Company Short-Term Debt|TXG (10xgenomics.com) - Company Short-Term Indebtedness|Intellia Therapeutics, Inc. (NTLA) - Company Short-Term Debt|Short-Term Debt Stoke Therapeutics Inc (STOK)|Company Current Liabilities BLFS|WVE: Company Short-Term Loans and Borrowings|Company Short-Term Debts MAZE|sionnatx.com (SION) - Short-Term Indebtedness|Company Short-Term Debts PRME (Prime Medicine)|Taysha Gene Therapies Inc (TSHA) - Short-Term Debt|QURE - Company Short-Term Debt|MGTX (MeiraGTx Corp) - Company Short-Term Indebtedness|REGENXBIO Inc. (RGNX) - Company Short-Term Debt|Short-Term Debt solidbio.com (SLDB)|Company Short-Term Debt Ocugen|Company Current Liabilities Pacific Biosciences of California, Inc. (PACB)|Company Short-Term Debts BNTC|Short-Term Debt Volume Design Corp|Company Short-Term Debts RCKT (Rocket Pharmaceuticals)|FDMT - Company Current Liabilities|LXEO - Company Short-Term Debt|Short-Term Debt Volume Korro Bio, Inc. KRRO|EDIT (Editas) - Company Current Liabilities|Silence Therapeutics Corp - Company Short-Term Loans and Borrowings|PRQR (ProQR) - Company Short-Term Debts|Codexis Bio (CDXS) - Short-Term Debt Volume|Company Short-Term Debt Sangamo Therapeutics, Inc. (SGMO)|nautilus.bio - Company Short-Term Indebtedness|Company Short-Term Debts MGX (Metagenomi, Inc)|DTIL - Company Current Liabilities|GBIO: Company Current Liabilities|Short-Term Debt Volume boundlessbio.com BOLD|XCUR: Company Short-Term Debts|IMNN (Imunon) - Company Short-Term Debt|Company Short-Term Debt Phio Pharmaceuticals Corp|Company Short-Term Indebtedness MBIO (Mustang Bio Corp)|Company Short-Term Debts RNAZ|adnas.com (APDN) - Short-Term Indebtedness|Company Short-Term Debt bluebird bio BLUE|ImmunoPrecise Antibodies Ltd (IPA) - Short-Term Debt|Omega - Company Short-Term Debts|OMIC (Singular Genomics Corp) - Company Short-Term Indebtedness|Regulus Therapeutics (RGLS) - Company Short-Term Debt|Company Short-Term Indebtedness SYRS|TBIO (Telesis Bio) - Company Short-Term Debts|Company Short-Term Debts TRACON Pharmaceuticals Inc.|Company Short-Term Debts UBX